Rheumatology Therapeutics Market Expected to Reach USD 59.1 Billion by 2032, Driven by Rising Autoimmune Disease Prevalence and Surging Geriatric Population The global Rheumatology Therapeutics Market, valued at approximately USD 49.04 billion in 2024, is projected to grow to around USD 59.10 billion by 2032, propelled by increasing prevalence of rheumatic and autoimmune disorders, a...